Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis

Leishmaniasis is a neglected tropical disease affecting more than 12 million people worldwide, which in its visceral clinical form (VL) is characterised by the accumulation of parasites in the liver and spleen, and can lead to death if not treated. Available treatments are not well tolerated due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bezerra-Souza, Adriana, Fernandez-Garcia, Raquel, Rodrigues, Gabriela F., Bolas-Fernandez, Francisco, Dalastra Laurenti, Marcia, Passero, Luiz Felipe, Lalatsa, Aikaterini, Serrano, Dolores R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680852/
https://www.ncbi.nlm.nih.gov/pubmed/31330776
http://dx.doi.org/10.3390/pharmaceutics11070353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680852/
https://www.ncbi.nlm.nih.gov/pubmed/31330776
http://dx.doi.org/10.3390/pharmaceutics11070353

Ejemplares similares